OCULAR THERAPEUTIX, INC (OCUL) Current Ratio
- Current ratio · latest quarter: Value 13.11×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 13.11× | Current assets / current liabilities. $644.43M ÷ $49.17M ≈ 13.11× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 644.43M USD | Assets, Current |
| Current obligations | 49.17M USD | Liabilities, Current |
| Cash and equivalents | 598.64M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 30.26M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.83M USD | Inventory, Net |
| Payables | 7.00M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $644.43M | $49.17M | $598.64M | (m) | $30.26M | $3.83M | $7.00M | (m) | 13.11× |
| 2026-03-31 | $706.00M | $47.68M | $666.70M | (m) | $24.35M | $3.74M | $8.03M | (m) | 14.81× |
| 2025-12-31 | $782.13M | $50.81M | $737.06M | (m) | $30.65M | $3.56M | $4.15M | (m) | 15.39× |
| 2025-09-30 | $386.98M | $49.29M | $344.77M | (m) | $30.77M | $3.49M | $6.26M | (m) | 7.85× |
| 2025-06-30 | $433.38M | $42.93M | $391.13M | (m) | $30.41M | $3.04M | $5.89M | (m) | 10.09× |
| 2025-03-31 | $387.69M | $37.93M | $349.68M | (m) | $25.22M | $3.27M | $4.63M | (m) | 10.22× |
| 2024-12-31 | $440.99M | $41.35M | $392.10M | (m) | $32.39M | $3.04M | $4.18M | (m) | 10.66× |
| 2024-09-30 | $473.01M | $36.36M | $427.22M | (m) | $30.23M | $2.40M | $4.00M | (m) | 13.01× |
| 2024-06-30 | $498.58M | $29.97M | $459.69M | (m) | $30.23M | $2.55M | $3.69M | (m) | 16.64× |
| 2024-03-31 | $519.82M | $24.30M | $482.89M | (m) | $26.55M | $2.57M | $6.45M | (m) | 21.39× |
| 2023-12-31 | $232.24M | $34.90M | $195.81M | (m) | $26.18M | $2.31M | $4.39M | (m) | 6.66× |
| 2023-09-30 | $141.26M | $35.07M | $110.55M | (m) | $23.59M | $2.26M | $3.98M | (m) | 4.03× |
| 2023-06-30 | $100.71M | $32.36M | $66.61M | (m) | $27.31M | $2.20M | $3.57M | (m) | 3.11× |
| 2023-03-31 | $107.16M | $29.71M | $79.03M | (m) | $21.12M | $2.27M | $5.44M | (m) | 3.61× |
| 2022-12-31 | $129.63M | $31.39M | $102.30M | (m) | $21.32M | $1.97M | $5.12M | (m) | 4.13× |
| 2022-09-30 | $145.62M | $29.27M | $120.95M | (m) | $19.80M | $1.54M | $5.31M | (m) | 4.98× |
| 2022-06-30 | $160.32M | $26.11M | $134.54M | (m) | $20.48M | $1.50M | $3.70M | (m) | 6.14× |
| 2022-03-31 | $174.65M | $23.96M | $145.42M | (m) | $23.21M | $1.36M | $3.42M | (m) | 7.29× |
| 2021-12-31 | $191.30M | $26.34M | $164.16M | (m) | $21.14M | $1.25M | $4.59M | (m) | 7.26× |
| 2021-09-30 | $203.93M | $25.16M | $179.28M | (m) | $19.55M | $1.22M | $4.25M | (m) | 8.11× |
| 2021-06-30 | $216.52M | $21.55M | $191.86M | (m) | $18.73M | $1.11M | $3.88M | (m) | 10.05× |
| 2021-03-31 | $228.13M | $27.44M | $209.38M | (m) | $13.63M | $1.12M | $4.15M | (m) | 8.31× |
| 2020-12-31 | $246.16M | $26.66M | $228.06M | (m) | $12.25M | $1.20M | $2.71M | (m) | 9.23× |
| 2020-09-30 | $81.90M | $22.91M | $70.64M | (m) | $7.78M | $1.15M | $3.24M | (m) | 3.58× |
| 2020-06-30 | $90.29M | $13.80M | $84.29M | (m) | $2.87M | $1.07M | $2.65M | (m) | 6.54× |
| 2020-03-31 | $55.15M | $11.11M | $48.15M | (m) | $3.43M | $1.11M | $2.84M | (m) | 4.96× |
| 2019-12-31 | $60.17M | $12.03M | $54.44M | (m) | $2.55M | $954.00K | $3.27M | (m) | 5.00× |
| 2019-09-30 | $69.64M | $11.01M | $65.41M | (m) | $1.11M | $895.00K | $3.46M | (m) | 6.33× |
| 2019-06-30 | $65.44M | $10.13M | $61.77M | (m) | $615.00K | $762.00K | $4.04M | (m) | 6.46× |
| 2019-03-31 | $79.17M | $8.61M | $76.25M | (m) | $276.00K | $265.00K | $3.90M | (m) | 9.19× |
| 2018-12-31 | $56.19M | $9.16M | $54.06M | (m) | $201.00K | $217.00K | $2.96M | (m) | 6.14× |
| 2018-09-30 | $58.27M | $13.41M | $56.86M | (m) | $240.00K | $102.00K | $2.78M | (m) | 4.35× |
| 2018-06-30 | $58.47M | $11.90M | $56.83M | (m) | $285.00K | $131.00K | $2.14M | (m) | 4.91× |
| 2018-03-31 | $64.48M | $13.15M | $62.91M | (m) | $170.00K | $139.00K | $3.48M | (m) | 4.90× |
| 2017-12-31 | $43.34M | $13.43M | $41.54M | (m) | $226.00K | $122.00K | $3.57M | (m) | 3.23× |
| 2017-09-30 | $52.45M | $10.95M | $51.16M | (m) | $278.00K | $127.00K | $2.60M | (m) | 4.79× |
| 2017-06-30 | $68.33M | $13.13M | $63.05M | $3.00M | (m) | $90.00K | $6.31M | (m) | 5.20× |
| 2017-03-31 | $83.28M | $8.66M | $54.68M | $25.70M | (m) | $96.00K | $3.75M | (m) | 9.62× |
| 2016-12-31 | $69.90M | $8.30M | $32.94M | $35.21M | $250.00K | $113.00K | $2.12M | (m) | 8.42× |
| 2016-09-30 | $76.82M | $8.24M | $52.23M | $23.51M | (m) | $126.00K | $1.68M | (m) | 9.32× |
| 2016-06-30 | $84.97M | $6.42M | $48.17M | $35.72M | (m) | $149.00K | $1.61M | (m) | 13.24× |
| 2016-03-31 | $97.10M | $6.00M | $46.21M | $49.24M | (m) | $127.00K | $2.06M | (m) | 16.17× |
| 2015-12-31 | $106.98M | $5.38M | $30.78M | $74.28M | $193.00K | $134.00K | $1.96M | (m) | 19.89× |
| 2015-09-30 | $115.90M | $11.18M | $41.20M | $72.44M | $189.00K | $147.00K | $1.62M | (m) | 10.37× |
| 2015-06-30 | $126.64M | $9.59M | $78.69M | $45.04M | $164.00K | $145.00K | $2.81M | (m) | 13.20× |
| 2015-03-31 | $69.47M | $7.23M | $12.52M | $54.90M | $352.00K | $158.00K | $2.19M | (m) | 9.61× |
| 2014-12-31 | $76.18M | $5.87M | $37.39M | $37.44M | $329.00K | $133.00K | $1.32M | (m) | 12.97× |
| 2014-09-30 | $82.27M | $3.38M | $80.89M | (m) | $53.00K | $117.00K | $649.00K | (m) | 24.35× |
| 2014-06-30 | $22.59M | $4.49M | $19.94M | (m) | $60.00K | $109.00K | $1.52M | (m) | 5.03× |
| 2013-12-31 | $18.01M | $3.34M | $17.50M | $0.00 | $250.00K | (m) | $545.00K | (m) | 5.39× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |